SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009690
Filing Date
2022-05-12
Accepted
2022-05-12 16:24:07
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20220331.htm   iXBRL 10-Q 2409156
2 EX-31.1 acet-ex31_1.htm EX-31.1 18900
3 EX-31.2 acet-ex31_2.htm EX-31.2 19180
4 EX-32.1 acet-ex32_1.htm EX-32.1 15283
  Complete submission text file 0000950170-22-009690.txt   8986803

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220331_lab.xml EX-101.LAB 579446
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acet-20220331_cal.xml EX-101.CAL 54924
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220331.xsd EX-101.SCH 78625
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220331_pre.xml EX-101.PRE 436470
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20220331_def.xml EX-101.DEF 253772
70 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220331_htm.xml XML 1523095
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 22918192
SIC: 2834 Pharmaceutical Preparations